These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26202400)

  • 1. The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma.
    Ayuso C; Bruix J
    Hepatol Int; 2014 Jan; 8(1):4-6. PubMed ID: 26202400
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ongoing challenges in the diagnosis of hepatocellular carcinoma.
    Terzi E; Salvatore V; Negrini G; Piscaglia F
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):451-63. PubMed ID: 26603785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
    Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma.
    Maruyama K; Yoshikawa M; Yokosuka O
    JNMA J Nepal Med Assoc; 2008; 47(171):156-66. PubMed ID: 19079385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma.
    Goshima S; Kanematsu M; Kondo H; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2009 Mar; 192(3):686-92. PubMed ID: 19234264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.
    Bhartia B; Ward J; Guthrie JA; Robinson PJ
    AJR Am J Roentgenol; 2003 Mar; 180(3):577-84. PubMed ID: 12591657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the imaging of hepatocellular carcinoma.
    You MW; Kim SY; Kim KW; Lee SJ; Shin YM; Kim JH; Lee MG
    Clin Mol Hepatol; 2015 Mar; 21(1):95-103. PubMed ID: 25834808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors.
    Yamamoto K; Shiraki K; Nakanishi S; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Fuke H; Hashimoto A; Shimizu A; Okuda Y; Nakano T
    Int J Oncol; 2003 Feb; 22(2):353-8. PubMed ID: 12527934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.
    Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    J Med Ultrason (2001); 2003 Sep; 30(3):141-51. PubMed ID: 27278304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced agent detection imaging: Early experience in hepatocellular carcinoma.
    Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    J Med Ultrason (2001); 2003 Jun; 30(2):77-84. PubMed ID: 27278162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging.
    Shimofusa R; Ueda T; Kishimoto T; Nakajima M; Yoshikawa M; Kondo F; Ito H
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):583-9. PubMed ID: 19809781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma: overcoming challenges in disease management.
    Gish RG
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):252-61. PubMed ID: 16527686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular Carcinoma in the Cirrhotic Liver: Evaluation Using Computed Tomography and Magnetic Resonance Imaging.
    Coskun M
    Exp Clin Transplant; 2017 Mar; 15(Suppl 2):36-44. PubMed ID: 28301997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
    Oliver JH; Baron RL; Federle MP; Rockette HE
    AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
    Park YS; Lee CH; Kim JW; Shin S; Park CM
    World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of small hepatocellular carcinoma--imaging diagnosis and significance of tumor biopsy.
    Horigome H; Nomura T; Saso K; Joh T; Ohara H; Akita S; Sobue S; Mizuno Y; Kato Y; Kanematsu T; Murasaki G; Itoh M
    Hepatogastroenterology; 2000; 47(36):1659-62. PubMed ID: 11149027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging.
    Qu P; Yu X; Liang P; Cheng Z; Han Z; Liu F; Yu J
    Ultrasound Med Biol; 2013 Sep; 39(9):1571-9. PubMed ID: 23830098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of new contrast harmonic technique for detecting tumor vascularity in hepatocellular carcinoma: Preliminary results.
    Wen YL; Kudo M; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    J Med Ultrason (2001); 2003 Jun; 30(2):85-92. PubMed ID: 27278163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.